Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02433990 · ClinicalTrials.gov registry record
Risk Factors for Acquired Cardiovascular Disease in Adults With Congenital Heart Disease
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 178
- Enrollment target
NCT02433990: Completed study, sponsored by Stanford University.
NCT02433990 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 178 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02433990 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 178 participants
- Enrollment target
Study Summary
This research study is to determine the risk factors for acquired heart disease, in adults with congenital heart disease. This knowledge is important to develop and target ways to prevent or delay the onset of acquired heart disease in adults with congenital heart disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2014-04 |
| Est. Completion | 2019-08-24 |
What the finished NCT02433990 record still lists
NCT02433990 is an observational study that tracks outcomes without assigning an intervention. The registered 178 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02433990 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02433990 about?
NCT02433990 is a clinical study titled "Risk Factors for Acquired Cardiovascular Disease in Adults With Congenital Heart Disease". This research study is to determine the risk factors for acquired heart disease, in adults with congenital heart disease. This knowledge is important to develop and target ways to prevent or delay the onset of acquired heart disease in adults with congenital heart disease.
What is the current status of trial NCT02433990?
This trial is currently completed. The enrollment target is 178 participants. The study started on 2014-04. Estimated completion is 2019-08-24.
Who is sponsoring clinical trial NCT02433990?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03642002 · 178 participants · NA
The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU
- NCT04227847 · 178 participants · Phase 1
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
- NCT04855214 · 178 participants
Evaluating the Experience of Upper Limb Prosthesis Use
- NCT05391126 · 178 participants · NA
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia